Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers

被引:105
|
作者
Carcangiu, ML
Radice, P
Manoukian, S
Spatti, G
Gobbo, M
Pensotti, V
Crucianelli, R
Pasini, B
机构
[1] Ist Nazl Tumori, Dept Pathol, I-20133 Milan, Italy
[2] Ist Nazl Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[3] Ist Nazl Tumori, Dept Prevent & Predict Med, I-20133 Milan, Italy
[4] Ist Nazl Tumori, Gynecol Unit, I-20133 Milan, Italy
[5] FIRC, Inst Mol Oncol, Milan, Italy
关键词
BRCA1; prophylactic salpingo-oophorectomy; fallopian tube; atypical hyperplasia; carcinoma in situ;
D O I
10.1097/01.pgp.0000101082.35393.84
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Although growing numbers of tubal carcinomas in carriers of BRCA1 and BRCA2 germline mutations have been reported, very little is known about the nature and frequency of their possible precursor lesions. The aim of this study is to investigate the occurrence of atypical proliferative tubal lesions in grossly normal fallopian tubes from 26 women with BRCA1 and BRCA2 germline mutations who underwent prophylactic salpingo-ooophorectomy and whose ovaries were histologically negative for carcinoma. Fallopian tubes from 49 women who had undergone hysterectomy with salpingo-oophorectomy for uterine leiomyoma served as controls. In the 22 BRCA1-mutated women, there were two in situ carcinomas and two atypical hyperplasias of the tubal epithelium. The tubes of the BRCA2-mutated women and of the 49 control women did not show any atypical proliferation. The frequency of proliferative lesions of the tubal epithelium, including in situ carcinoma, appears to be increased in BRCA1 mutation carriers. Removal and thorough examination of the fallopian tubes at the time of surgical prophylaxis for ovarian cancer is therefore recommended.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 50 条
  • [1] Does precursor lesion of fallopian tube carcinoma exist in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers? A preliminary study
    Royal, Virginie
    Penault-Llorca, Frederique
    Abaji, Christine
    Lussier, Christian
    Benayoun, Serge
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Tonin, Patricia
    Maugard, Christine
    MODERN PATHOLOGY, 2006, 19 : 103 - 103
  • [2] Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers?
    Vyarvelska, Iryna
    Rosen, Barry
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 219 - 221
  • [4] Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers
    Bradbury, Angela R.
    Ibe, Comfort. N.
    Dignam, James J.
    Cummings, Shelly A.
    Verp, Marion
    White, Melody A.
    Artioli, Grazia
    Dudlicek, Laura
    Olopade, Olufunmilayo L.
    GENETICS IN MEDICINE, 2008, 10 (03) : 161 - 166
  • [5] Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers
    Kerstin Rhiem
    Dolores Foth
    Barbara Wappenschmidt
    Heidrun Gevensleben
    Reinhard Büttner
    Uwe Ulrich
    Rita K. Schmutzler
    Archives of Gynecology and Obstetrics, 2011, 283 : 623 - 627
  • [6] Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers
    Rhiem, Kerstin
    Foth, Dolores
    Wappenschmidt, Barbara
    Gevensleben, Heidrun
    Buettner, Reinhard
    Ulrich, Uwe
    Schmutzler, Rita K.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (03) : 623 - 627
  • [7] Occult cancer of the fallopian tube in a BRCA2 germline mutation carrier at prophylactic salpingo-oophorectomy
    McEwen, AR
    McConnell, DT
    Kenwright, DN
    Gaskell, DJ
    Cherry, A
    Kidd, AMJ
    GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 992 - 994
  • [8] Can bilateral prophylactic salpingo-oophorectomy reduce cancer mortality in carriers of a BRCA1 or BRCA2 mutation?
    Brekelmans, CTM
    Seynaeve, C
    LANCET ONCOLOGY, 2006, 7 (03): : 191 - 193
  • [9] Prophylactic salpingo-oophorectomy in a population of BRCA1 and BRCA2 carriers: experience of the Institut Curie
    Laki, Fatima
    Kirova, Youlia M.
    Salmon, Remy
    Fitoussi, Alfred
    Sigal-Zafrani, Brigitte
    Asselain, Bernard
    Clough, Krishna
    Stoppa-Lyonnet, Dominique
    CANCER RESEARCH, 2006, 66 (08)
  • [10] Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation
    Laki, Fatima
    Kirova, Youlia M.
    This, Pascale
    Plancher, Corinne
    Asselain, Bernard
    Sastre, Xavier
    Stoppa-Lyonnet, Dominique
    Salmon, Remy
    CANCER, 2007, 109 (09) : 1784 - 1790